Clinical trials
Diagnosis clinical trials
Below are recruiting diagnosis clinical trials, each written for real people, not researchers. We’re tracking 927 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07510321Recruiting
A study of FL-261 imaging for cancer diagnosis
This trial tests a new imaging agent called FL-261 to help doctors see and stage cancers more clearly. If you have a known or suspected cancer like lung, colon, or head and neck cancer, this study may improve how your cancer is evaluated.
Wuhan, HubeiAges 18 years+ - NCT07510724Recruiting
Real-world study of Tislelizumab for lung cancer
This trial collects information on how well the immunotherapy drug Tislelizumab works for different types of lung cancer. It is meant for people whose doctor already decided to prescribe this drug as part of their care.
Sankt Pölten, Lower AustriaAges 18 years+ - NCT07513038RecruitingPhase 1/Phase 2
Using dye imaging to diagnose bile duct blockage in infants
This trial tests whether a special fluorescent dye called indocyanine green (ICG) can help doctors better diagnose biliary atresia—a rare condition where a baby's bile ducts don't form properly. The dye is used during an imaging scan to light up the bile system so doctors can see it more clearly.
Boston, MassachusettsAges birth–3 months - NCT07514897Recruiting
Urine test to detect bladder cancer using CREPT protein
This study tests whether a protein called CREPT found in urine can help doctors diagnose bladder cancer or monitor patients who already have it. Researchers will compare urine samples from people with bladder cancer, people with other bladder conditions, and healthy volunteers.
Beijing, Chaoyang DistrictAges 18–75 - NCT07515989Recruiting
Testing a nerve biopsy method to diagnose leprosy
This study tests a new way to diagnose leprosy by taking a tiny sample from a nerve under the skin using ultrasound guidance. The goal is to see if this method can accurately detect leprosy and help doctors know when treatment is working.
Brasília, Federal DistrictAges 14 years+ - NCT07516886Recruiting
Early PSA levels after prostate surgery and cancer outcomes
This study looks at how PSA (a blood marker) levels measured shortly after prostate removal surgery can predict whether cancer comes back. Researchers hope this helps doctors identify patients who may need closer monitoring or additional treatment after surgery.
Kaunas, KaunoAges 18 years+ - NCT07516964Recruiting
Studying autoimmune kidney disease in children and adults
This study collects medical information and samples from patients with podocytopathy—a type of autoimmune kidney disease that causes protein leakage into urine. Researchers will analyze your medical records and any blood or kidney tissue samples you've already had to better understand the disease and find better treatments.
Rochester, MinnesotaAges birth–99 years - NCT07517432Recruiting
Registry tracking robotic surgery outcomes in gastric cancer
This study follows patients with stomach cancer who have robotic-assisted surgery to understand how well this advanced surgical approach works. By collecting information from multiple hospitals worldwide, researchers can learn what outcomes patients experience and how to improve care.
Hong KongAges Any age - NCT07518446Recruiting
Health Screening for Adults Starting Psychiatric Care
This study checks the physical health of adults beginning treatment for serious mental illnesses like schizophrenia or depression at two Danish clinics. It aims to catch health problems early that people with these conditions often experience.
CopenhagenAges 18 years+ - NCT07529847Recruiting
Breathing Techniques to Help Asthma Control
This study compares two special breathing techniques—alternating which nostril you breathe through and a method called Buteyko breathing—to see which helps asthma patients breathe easier and improve lung function. You'll practice these techniques and we'll measure how well they work for you.
IslamabadAges 18–45 - NCT07538947Recruiting
Real-time imaging to diagnose lung cancer faster and safer
This trial tests a new camera tool (confocal laser endomicroscopy) that lets doctors see lung tissue in real-time during a biopsy procedure. The goal is to diagnose non-small cell lung cancer more quickly and safely than standard biopsies alone.
NancyAges 18 years+ - NCT07541937Recruiting
Blood Flow Patterns to Predict Ectopic Pregnancy Treatment Success
This study looks at how blood flow patterns around an ectopic pregnancy (pregnancy outside the uterus, in the fallopian tube) might predict whether medication or watchful waiting will work for you. Ectopic pregnancies cannot result in a baby and need treatment; this research aims to help doctors choose the best approach.
Kfar Saba, IsraelAges 18–45 - NCT07542509Recruiting
Digital sound analysis for newborn heart screening
This study uses digital technology to analyze heart sounds in newborns under 30 days old. The goal is to develop a simple, non-invasive way to detect heart problems early using sound recordings.
Bologna, BOAges 1 week–4 weeks - NCT07543601Recruiting
Better COPD care for people evaluated for lung cancer
This trial tests whether people being checked for possible lung cancer can also get improved care for a breathing condition called COPD (chronic obstructive pulmonary disease). It focuses on patients whose lung function tests show airflow problems.
VejleAges 18 years+ - NCT07551466Recruiting
AI tool to detect early stomach cancer from endoscopy images
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
SuzhouAges 18–80 - NCT07552285Recruiting
New MRI imaging for better prostate cancer detection
This study tests whether new MRI imaging methods can better identify and grade prostate cancer in men with elevated PSA levels. You would get an MRI scan to help doctors see if cancer is present and how aggressive it might be.
Suzhou, JiangsuAges 20–90 - NCT07552467Recruiting
PET Imaging Scan for Detecting Cancer Using New Radioactive Tracer
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
Wuhan, HubeiAges 18 years+ - NCT07552584Recruiting
Blood test to screen for early lung cancer in COPD patients
This study uses an AI-powered blood test to identify people at high risk for lung cancer early, before symptoms appear. You'd be helping researchers see if this blood test can catch lung cancer sooner in people with COPD who have a smoking history.
VejleAges 50 years+ - NCT07553676Recruiting
Blood test study to diagnose endometriosis
This study tests whether a new blood test can accurately detect endometriosis (tissue similar to uterine lining growing outside the uterus). You may qualify if you menstruate regularly, are between 14–49 years old, and either have confirmed endometriosis, had a negative laparoscopy (a scope procedure), or have no endometriosis symptoms.
LinzAges 14–49 - NCT07553754Recruiting
Blood test to predict prostate cancer spread to bones
This study examines special particles in your blood called exosomes to see if they can predict whether prostate cancer might spread to your bones. Researchers will collect a blood sample before any cancer treatment to look for RNA signatures that might indicate bone metastasis risk.
Lanzhou, GansuAges 18 years+ - NCT07555223Recruiting
Using 3D Scans to Better Detect Tooth Decay
This study tests whether special 3D imaging and intraoral scanning tools can help dentists better identify tooth decay and plaque buildup. Researchers want to see if these new methods work well and could improve how cavities are diagnosed.
Wondelgem, BotestraatAges 18–70 - NCT07558863RecruitingPhase 4
GLP-1 medication's effect on nerve damage in type 2 diabetes
This study tests whether a GLP-1 medication (a type of diabetes drug) can help protect nerves in the heart from damage caused by diabetes. If you have type 2 diabetes and are overweight, this trial might help researchers understand if this medication improves how your heart's nervous system works.
Nanjing, JiangsuAges 18–70 - NCT07559201Recruiting
Radionuclide imaging scans for prostate cancer detection
This study compares two types of special imaging scans (PET/CT scans) to see which one better detects prostate cancer or its recurrence. You would undergo both scans as part of the research to help doctors improve how they find and treat prostate cancer.
Guilin, GuangxiAges 18 years+ - NCT07560852Recruiting
How Endotest affects women's daily life and wellbeing
This study asks women taking Endotest (a saliva-based hormone test) about how it affects their quality of life and wellbeing. Researchers want to understand whether using this test helps women feel more confident about their health decisions.
Bordeaux, GirondeAges 18–43
Hear when a new Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diagnosis?
- Yes. Clin2 currently lists 927 recruiting diagnosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diagnosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diagnosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.